{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:03:35Z","timestamp":1746763415420,"version":"3.40.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["2023AH053301"],"award-info":[{"award-number":["2023AH053301"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02588-5","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T10:46:33Z","timestamp":1746701193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple machine learning algorithms identify 13 types of cell death-critical genes in large and multiple non-alcoholic steatohepatitis cohorts"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7441-6564","authenticated-orcid":false,"given":"Renao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0357-5590","authenticated-orcid":false,"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"2588_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu X, Poulsen KL, Wu L, Liu S, Miyata T, Song Q, Wei Q, Zhao C, Lin C, Yang J. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct Target Ther. 2022;7:287.","journal-title":"Signal Transduct Target Ther"},{"key":"2588_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","volume":"73","author":"Y Saiman","year":"2022","unstructured":"Saiman Y, Duarte-Rojo A, Rinella ME. Fatty Liver Disease: Diagnosis and Stratification. Annu Rev Med. 2022;73:529\u201344.","journal-title":"Annu Rev Med"},{"key":"2588_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH. trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2588_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD. distinct clinicopathologic meanings. Hepatology. 2011;53:810\u201320. https:\/\/doi.org\/10.1002\/hep.24127.","journal-title":"Hepatology"},{"key":"2588_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","volume":"8","author":"MA Tincopa","year":"2023","unstructured":"Tincopa MA, Loomba R. Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lancet Gastroenterol Hepatol. 2023;8:660\u201370.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2588_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"2588_CR7","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Younossi Z, Natarajan Y, Bugianesi E, Rinella ME, Harrison SA, Mantzoros C, Pfotenhauer K, Klein S, et al. Preparing for the NASH Epidemic: A Call to Action. Gastroenterology. 2021;161:1030-1042.e1038.","journal-title":"Gastroenterology"},{"key":"2588_CR8","doi-asserted-by":"publisher","first-page":"S302","DOI":"10.3350\/cmh.2022.0329","volume":"29","author":"WQ Leow","year":"2023","unstructured":"Leow WQ, Chan AW, Mendoza PGL, Lo R, Yap K, Kim H. Non-alcoholic fatty liver disease: the pathologist\u2019s perspective. Clin Mol Hepatol. 2023;29:S302-s318.","journal-title":"Clin Mol Hepatol"},{"key":"2588_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","volume":"2","author":"F Piccinino","year":"1986","unstructured":"Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986;2:165\u201373.","journal-title":"J Hepatol"},{"key":"2588_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol. 2023;78:415\u201329.","journal-title":"J Hepatol"},{"key":"2588_CR11","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM. Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology. 2016;150:1769\u201377.","journal-title":"Gastroenterology"},{"key":"2588_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15:349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2588_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2022.0237","volume":"29","author":"KC Lee","year":"2023","unstructured":"Lee KC, Wu PS, Lin HC. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clin Mol Hepatol. 2023;29:77\u201398.","journal-title":"Clin Mol Hepatol"},{"key":"2588_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol. 2018;68:280\u201395.","journal-title":"J Hepatol"},{"key":"2588_CR15","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Tabas I, Pajvani UB. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. Gastroenterology. 2020;158:1913\u201328.","journal-title":"Gastroenterology"},{"key":"2588_CR16","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s12276-023-01078-x","volume":"55","author":"W Park","year":"2023","unstructured":"Park W, Wei S, Kim BS, Kim B, Bae SJ, Chae YC, Ryu D, Ha KT. Diversity and complexity of cell death: a historical review. Exp Mol Med. 2023;55:1573\u201394.","journal-title":"Exp Mol Med"},{"key":"2588_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12944-024-02122-z","volume":"23","author":"L Dai","year":"2024","unstructured":"Dai L, Jiang R, Zhan Z, Zhang L, Qian Y, Xu X, Yang W, Zhang Z. Machine learning-based algorithm identifies key mitochondria-related genes in non-alcoholic steatohepatitis. Lipids Health Dis. 2024;23:137.","journal-title":"Lipids Health Dis"},{"key":"2588_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12944-023-01988-9","volume":"23","author":"L Dai","year":"2024","unstructured":"Dai L, Yuan W, Jiang R, Zhan Z, Zhang L, Xu X, Qian Y, Yang W, Zhang Z. Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis. Lipids Health Dis. 2024;23:23.","journal-title":"Lipids Health Dis"},{"key":"2588_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"2588_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.surg.2023.05.023","volume":"174","author":"JH Cabot","year":"2023","unstructured":"Cabot JH, Ross EG. Evaluating prediction model performance. Surgery. 2023;174:723\u20136.","journal-title":"Surgery"},{"key":"2588_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nbt0308-303","volume":"26","author":"M Ringn\u00e9r","year":"2008","unstructured":"Ringn\u00e9r M. What is principal component analysis? Nat Biotechnol. 2008;26:303\u20134.","journal-title":"Nat Biotechnol"},{"key":"2588_CR22","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, Chen J, Jiang W, Yang K, Ou Q, et al. Cell Marker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51:D870-d876.","journal-title":"Nucleic Acids Res"},{"key":"2588_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"key":"2588_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.26502\/jbsb.5107072","volume":"6","author":"T Liefeld","year":"2023","unstructured":"Liefeld T, Huang E, Wenzel AT, Yoshimoto K, Sharma AK, Sicklick JK, Mesirov JP, Reich M. NMF Clustering: Accessible NMF-based Clustering Utilizing GPU Acceleration. J Bioinform Syst Biol. 2023;6:379\u201383.","journal-title":"J Bioinform Syst Biol"},{"key":"2588_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67:862\u201373.","journal-title":"J Hepatol"},{"key":"2588_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"key":"2588_CR27","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic Steatohepatitis: A Review. Jama. 2020;323:1175\u201383.","journal-title":"Jama"},{"key":"2588_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"2588_CR29","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","volume":"56","author":"K Tokushige","year":"2021","unstructured":"Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, Akuta N, Yoneda M, Iwasa M, Yoneda M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56:951\u201363.","journal-title":"J Gastroenterol"},{"key":"2588_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M. Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol. 2018;53:362\u201376.","journal-title":"J Gastroenterol"},{"key":"2588_CR31","doi-asserted-by":"publisher","first-page":"eadd3949","DOI":"10.1126\/scitranslmed.add3949","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, Li K, Pickholz E, Dobie R, Matchett KP, Henderson NC, Carrico C, Driver I, Borch Jensen M, Chen L, et al. An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis. Sci Transl Med. 2023;15:eadd3949.","journal-title":"Sci Transl Med"},{"key":"2588_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov K, J\u00f8rgensen SMD, Thomsen KL, M\u00f8ller HJ, Vilstrup H, George J, Schuppan D, Gr\u00f8nb\u00e6k H. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16:145\u201359.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2588_CR33","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"2588_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/hep.32620","volume":"77","author":"V Indira Chandran","year":"2023","unstructured":"Indira Chandran V, Wernberg CW, Lauridsen MM, Skytthe MK, Bendixen SM, Larsen FT, Hansen CD, Gr\u00f8nkj\u00e6r LL, Siersb\u00e6k MS, Caterino TD, et al. Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness. Hepatology. 2023;77:558\u201372.","journal-title":"Hepatology"},{"key":"2588_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF01543103","volume":"15","author":"S Romagnani","year":"1995","unstructured":"Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol. 1995;15:121\u20139.","journal-title":"J Clin Immunol"},{"key":"2588_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00054725-199911000-00009","volume":"5","author":"S Romagnani","year":"1999","unstructured":"Romagnani S. Th1\/Th2 cells. Inflamm Bowel Dis. 1999;5:285\u201394.","journal-title":"Inflamm Bowel Dis"},{"key":"2588_CR37","doi-asserted-by":"publisher","first-page":"101333","DOI":"10.1016\/j.ghir.2020.101333","volume":"53\u201354","author":"EA Jensen","year":"2020","unstructured":"Jensen EA, Young JA, Mathes SC, List EO, Carroll RK, Kuhn J, et al. Crosstalk between the growth hormone\/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology. Growth Hormon IGF Res. 2020;53\u201354:101333.","journal-title":"Growth Hormon IGF Res"},{"key":"2588_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/gut.2003.024505","volume":"54","author":"S Sanz","year":"2005","unstructured":"Sanz S. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut. 2005;54:134\u201341.","journal-title":"Gut"},{"key":"2588_CR39","doi-asserted-by":"publisher","first-page":"34605","DOI":"10.1038\/srep34605","volume":"6","author":"H Nishizawa","year":"2016","unstructured":"Nishizawa H, Iguchi G, Fukuoka H, Takahashi M, Suda K, Bando H, et al. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Sci Rep. 2016;6:34605.","journal-title":"Sci Rep"},{"key":"2588_CR40","doi-asserted-by":"publisher","first-page":"616044","DOI":"10.3389\/fimmu.2020.616044","volume":"11","author":"I Coelho","year":"2021","unstructured":"Coelho I, Duarte N, Barros A, Macedo MP, Penha-Gon\u00e7alves C. Trem-2 Promotes Emergence of Restorative Macrophages and Endothelial Cells During Recovery From Hepatic Tissue Damage. Front Immunol. 2021;11:616044.","journal-title":"Front Immunol"},{"key":"2588_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrgastro.2018.13","volume":"15","author":"K Ray","year":"2018","unstructured":"Ray K. A protective role for TREM2 in liver injury. Nat Rev Gastroenterol Hepatol. 2018;15:130\u20131.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2588_CR42","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","volume":"77","author":"T Hendrikx","year":"2022","unstructured":"Hendrikx T, Porsch F, Kiss MG, Rajcic D, Papac-Mili\u010devi\u0107 N, Hoebinger C, et al. Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH. J Hepatol. 2022;77:1373\u201385.","journal-title":"J Hepatol"},{"key":"2588_CR43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gutjnl-2017-314107","volume":"68","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria MJ, Esparza-Baquer A, Oakley F, Labiano I, Korosec A, Jais A, et al. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage. Gut. 2019;68:533\u201346.","journal-title":"Gut"},{"key":"2588_CR44","doi-asserted-by":"publisher","first-page":"e0260313","DOI":"10.1371\/journal.pone.0260313","volume":"16","author":"A Goyale","year":"2021","unstructured":"Goyale A, Jain A, Smith C, Papatheodoridi M, Misas MG, Roccarina D, et al. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. Strnad P, editor. PLoS ONE. 2021;16:e0260313.","journal-title":"PLoS ONE."}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02588-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02588-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02588-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:04:40Z","timestamp":1746705880000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02588-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2588"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02588-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical aspect of the study was aptly addressed, with the research protocol receiving due approval from the Ethics Committee of The First Affiliated Hospital of Anhui Medical University (Approval number: 2023497) (Supplementary Fig. 5). To uphold ethical standards, all participants provided their informed consent prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}